Los Angeles Capital Management’s MaxCyte MXCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$44.5K Hold
63,330
﹤0.01% 1519
2025
Q4
$95.6K Hold
63,330
﹤0.01% 1427
2025
Q3
$100K Hold
63,330
﹤0.01% 1319
2025
Q2
$138K Buy
+63,330
New +$153K ﹤0.01% 1233
2022
Q1
Sell
-34,220
Closed -$349K 1462
2021
Q4
$349K Buy
+34,220
New +$367K ﹤0.01% 1184

Other funds holding MXCT

Los Angeles Capital Management's MXCT Position: Q1 2026 in Review

Los Angeles Capital Management held its MaxCyte (MXCT) position steady in Q1 2026 at 63,330 shares worth $44.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1519.

Los Angeles Capital Management first reported a position in MXCT in Q4 2021 and has held it in 5 quarters since. The position peaked at $349K in Q4 2021. 130 funds tracked by Wall St. Rank hold MXCT as of Q1 2026.

  • Los Angeles Capital Management held 63,330 shares of MaxCyte worth $44.5K as of Q1 2026.
  • Los Angeles Capital Management left its MaxCyte share count unchanged in Q1 2026.
  • MaxCyte made up ﹤0.01% of Los Angeles Capital Management's portfolio in Q1 2026, its #1519 holding.
  • Los Angeles Capital Management first reported a position in MaxCyte in Q4 2021 and has held it in 5 quarters since.
  • Los Angeles Capital Management's MaxCyte position peaked at $349K in Q4 2021.
  • 130 funds tracked by Wall St. Rank held MaxCyte as of Q1 2026.

Based on Los Angeles Capital Management's 13F filing for Q1 2026, filed 8 May 2026.